These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3943010)

  • 1. Treatment of polycythemia vera with hydroxyurea.
    Sharon R; Tatarsky I; Ben-Arieh Y
    Cancer; 1986 Feb; 57(4):718-20. PubMed ID: 3943010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of polycythemia vera with hydroxyurea.
    Donovan PB; Kaplan ME; Goldberg JD; Tatarsky I; Najean Y; Silberstein EB; Knospe WH; Laszlo J; Mack K; Berk PD
    Am J Hematol; 1984; 17(4):329-34. PubMed ID: 6496458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly.
    Kirito K; Suzuki K; Miyamura K; Takeuchi M; Handa H; Okamoto S; Gadbaw B; Yamauchi K; Amagasaki T; Ito K; Hino M
    Int J Hematol; 2018 Feb; 107(2):173-184. PubMed ID: 28956263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan.
    Kreft A; Nolde C; Büsche G; Buhr T; Kreipe H; Georgii A
    Eur J Haematol; 2000 Jan; 64(1):32-41. PubMed ID: 10680703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
    Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
    Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pruritus secondary to hydroxyurea therapy in a woman with polycythemia vera.
    Vosburgh E
    Am J Hematol; 1992 Sep; 41(1):70. PubMed ID: 1503109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with hydroxyurea of polycythemia vera in a 11 year-old child].
    Vodoff MV; Nelken B; Vic P; Farriaux JP
    Arch Pediatr; 1996 Sep; 3(9):870-3. PubMed ID: 8949347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea in the treatment of polycythemia vera: a prospective study of 100 patients over a 20-year period.
    West WO
    South Med J; 1987 Mar; 80(3):323-7. PubMed ID: 3824016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea.
    Pulik M; Lionnet F; Genet P; Petitdidier C; Jary L; Touahri T
    Am J Hematol; 1996 Nov; 53(3):207-8. PubMed ID: 8895700
    [No Abstract]   [Full Text] [Related]  

  • 11. Polycythemia vera in a 12-year-old girl: a case report.
    Turker M; Ozer EA; Oniz H; Atabay B; Yaprak I
    Pediatr Hematol Oncol; 2002 Jun; 19(4):263-6. PubMed ID: 12051593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
    Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
    Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
    Boivin P
    Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
    Tóthová E; Nebesnáková E; Kafková A; Stecová N; Fricová M
    Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelomonocytic leukemia transformation in polycythemia vera.
    Holcombe RF; Treseler PA; Rosenthal DS
    Leukemia; 1991 Jul; 5(7):606-10. PubMed ID: 2072746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
    Alvarez-Larrán A; Martínez-Avilés L; Hernández-Boluda JC; Ferrer-Marín F; Antelo ML; Burgaleta C; Mata MI; Xicoy B; Martínez-Trillos A; Gómez-Casares MT; Durán MA; Marcote B; Ancochea A; Senín A; Angona A; Gómez M; Vicente V; Cervantes F; Bellosillo B; Besses C
    Ann Hematol; 2014 Dec; 93(12):2037-43. PubMed ID: 24981691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoma transformation in polycythaemia vera treated with hydroxyurea.
    Hawkins TE; Carter JM; Romeril KR; Jackson SR; Green GJ
    Am J Hematol; 1993 Dec; 44(4):290. PubMed ID: 8238005
    [No Abstract]   [Full Text] [Related]  

  • 18. Anesthesia for polycythemia vera.
    Sosis MB
    J Clin Anesth; 1990; 2(1):31-4. PubMed ID: 2178645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera: A propensity-matched study.
    Barbui T; Vannucchi AM; Finazzi G; Finazzi MC; Masciulli A; Carobbio A; Ghirardi A; Tognoni G
    Am J Hematol; 2017 Nov; 92(11):1131-1136. PubMed ID: 28699191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies].
    Najean Y
    Presse Med; 1992 Nov; 21(37):1753-7. PubMed ID: 1488420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.